Nelson Moss, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nelson Moss, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:04 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06807619 · A Study of Sotorasib in People With Brain TumorsMemorial Sloan Kettering Cancer Center · recruiting · Brain Tumor · principal investigator
- Ph2NCT06058988 · Trastuzumab Deruxtecan (T-DXd) for People With Brain CancerMemorial Sloan Kettering Cancer Center · recruiting · Brain Cancer, Glioblastoma, Metastatic Cancer · principal investigator
- Ph2NCT04690348 · Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II StudyMemorial Sloan Kettering Cancer Center · active not recruiting · Recurrent Brain Metastases · principal investigator
- Ph1NCT03465618 · A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain TumorsMemorial Sloan Kettering Cancer Center · active not recruiting · Brain Cancer, Pituitary Adenoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.